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RESEARCH ARTICLE
A homozygous FITM2 mutation causes a deafness-dystonia
syndrome with motor regression and signs of ichthyosis and
sensory neuropathy
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der Voet3,4, S. Sendhil Velan7,8, Bonnie Nijhof3,4, Jaap Oostrik1,4, Erik de Vrieze1,4, Radoslaw Katana5,
Atika Mansoor9, Martijn Huynen10, Radek Szklarczyk10, Martin Oti2,10,11, Lisbeth Tranebjærg12,13,14, Erwin van
Wijk1,4, Jolanda M. Scheffer-de Gooyert3,4, Saadat Siddique15, Jonathan Baets16,17,18, Peter de Jonghe16,17,18,
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Martin C. Göpfert5, Raheel Qamar22,23,‡, Annette Schenck3,4,‡, Hannie Kremer1,3,4,‡ and Saima Siddiqi9,‡
ABSTRACT
A consanguineous family from Pakistan was ascertained to have a
novel deafness-dystonia syndrome with motor regression, ichthyosis-
like features and signs of sensory neuropathy. By applying a combined
strategy of linkage analysis and whole-exome sequencing in
the presented family, a homozygous nonsense mutation, c.4G>T
(p.Glu2*), in FITM2 was identified. FITM2 and its paralog FITM1
constitute an evolutionary conserved protein family involved in
partitioning of triglycerides into cellular lipid droplets. Despite the role
of FITM2 in neutral lipid storage and metabolism, no indications for
lipodystrophy were observed in the affected individuals. In order to
obtain independent evidence for the involvement of FITM2 in the
human pathology, downregulation of the single Fitm ortholog,
CG10671, in Drosophila melanogaster was pursued using RNA
interference. Characteristics of the syndrome, including progressive
locomotor impairment, hearing loss and disturbed sensory functions,
were recapitulated in Drosophila, which supports the causative nature
of the FITM2mutation. Mutation-based genetic counseling can now be
provided to the family and insight is obtained into the potential impact of
genetic variation in FITM2.
KEY WORDS: FITM2, Lipid droplets, Drosophila, Hearing
impairment, Motor development, Dystonia
INTRODUCTION
Hearing involves the transformation of sounds into electrical signals
by the inner ear and the subsequent processing of these signals along
the central auditory pathways. Mutations in over a hundred genes
cause auditory malfunction and hearing impairment (http://
hereditaryhearingloss.org/). Defects in the proteins that function
in the inner ear can give rise to hearing impairment only (non-
syndromic) or, as the function of implicated proteins is often not
limited to the auditory system, they can result in multisystem
disorders (syndromic hearing impairment).
Deafness–dystonia syndromes are among the more than 400
syndromic forms of hearing impairment described to date (Toriello
et al., 2004; Kojovic et al., 2013a). Deafness–dystonia is clinically
and etiologically heterogeneous and in many of the investigated
cases the underlying causes remain elusive (Kojovic et al., 2013a,b).
For some of the cases with a causative mutation identified,
disruption of energy homeostasis and/or metabolism are emerging
as a common theme. This is true for Mohr–Tranebjaerg syndrome
(MIM# 304700, http://www.ncbi.nlm.nih.gov/omim) with
mutations in TIMM8A (MIM# 300356) (Jin et al., 1996), and for
a number of rare mitochondrial disorders with mutations in
mitochondrial genes as well as for SUCLA2-associated disease
(MIM #612073) (Carrozzo et al., 2007).
Cellular energy can be stored as neutral lipids in specialized
organelles, the lipid droplets (LDs) (Walther and Farese, 2012). LDs
also function in the modulation of cellular signaling, lipid
metabolism, transcriptional regulation, autophagy and immunityReceived 8 July 2016; Accepted 5 December 2016
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(Welte, 2015). Defects in genes that affect LD biogenesis and/or
function can be associated with hereditary lipodystrophies or motor
neuropathies without obvious effects on lipid storage and
metabolism (Fujimoto and Parton, 2011). Seipin, for example,
which is encoded by BSCL2 (MIM# 606158), is an endoplasmic
reticulum (ER) protein involved in LD formation and maintenance
as well as in adipocyte differentiation (Cui et al., 2011;Tian et al.,
2011). Loss-of-function mutations in BSCL2 lead to Berardinelli–
Seip congenital lipodystrophy (MIM# 269700), whereas gain-of-
toxic-function mutations in BSCL2 cause a motor neuron disease
(MIM# 600794) (Ito and Suzuki, 2009; Magré et al., 2001; Yagi
et al., 2011).
The fat storage-inducing transmembrane (FITM) protein family
consisting of two conserved proteins, FITM1 and FITM2, is
involved in LD partitioning and energy metabolism (Miranda et al.,
2011; Kadereit et al., 2008; Gross et al., 2010, 2011; Choudhary
et al., 2015). FITM1 (MIM# 612028) is primarily expressed in
skeletal muscle and, at lower levels, in heart. FITM2 (MIM#
612029) is ubiquitously expressed at low levels in brain, placenta,
skeletal muscle, heart, kidney, pancreas, liver, lung, spleen and
colon (Kadereit et al., 2008). Expression of FITM proteins in human
adipose tissue has not been described yet. In mouse, however, Fit2
expression is demonstrated to be highest in brown and white adipose
tissues (Kadereit et al., 2008). Deficiency of Fit2 in mouse adipose
tissue results in progressive lipodystrophy and postnatal whole body
Fit2 knockout is lethal (Miranda et al., 2014; Goh et al., 2015).
FITM2 is part of the FITM2–R3HDML–HNF4A locus that is
associated with type 2 diabetes, but no phenotypes in humans have
hitherto been ascribed specifically to either of the two FITM genes
(Cho et al., 2012).
In this study, we identified a homozygous truncating mutation in
FITM2 in a consanguineous family of Pakistani origin with Siddiqi
syndrome, a novel and characteristic combination of clinical
features of progressive sensorineural hearing impairment, delayed
development and regression of motor skills, dystonia, low body
mass index (BMI), an ichthosis-like appearance of the skin and
signs of a sensory neuropathy. No indications of a lipodystrophy
were present in the affected individuals. RNAi-induced gene
downregulation in Drosophila melanogaster recapitulated several
aspects of the human phenotype, supporting the link between the
syndrome and mutations in FITM2.
RESULTS
Clinical and paraclinical evaluations of the family
Clinical observations of affected individuals
A consanguineous family was identified from the Punjab region in
Pakistan with five siblings affected by syndromic hearing
impairment and three healthy siblings and parents (Fig. 1A). All
affected individuals had global developmental delay and
subsequent neuro-regression. Sensorineural hearing impairment
was the first symptom of the disease at the age of about six
months, and progressed to profound in about ten years (Fig. 1B).
Fig. 1. Pedigree of family W09-1008 and results
of pure tone audiometry. (A) Pedigree of the
family identified with Siddiqi syndrome and
segregation of the c.4G>T (p.Glu2*) mutation in
FITM2. (B) Pure tone audiometry of individuals II:1,
II:5 and II:6. Age (years) is indicated with the
symbol keys. The p95 lines indicate that 95% of
individuals of 19 years old have thresholds lower
than these. The arrows indicate that the thresholds
are lower than 120 dB.
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No intervention had been undertaken for the hearing impairment
of the affected individuals, whose speech was limited to single
words. Delayed motor development was evident in all five
affected individuals. Four of them only walked independently at
the age of three years, whereas individual II:6 never walked
independently. The three oldest affected individuals displayed
regression in their motor skills from six years of age, with a
gradual loss of head control and the ability to sit and walk by the
age of ten years. Fine motor skills were poor due to dystonic hand
movements and finger deformities. Affected individuals were able
to feed themselves but needed assistance in other daily living
tasks. Significant dystonic limb movements were present in three
cases and truncal dystonia was observed in individuals II:5 and
II:8. Contractures, including pes cavus deformities, were seen in
all three dystonic individuals due to long-standing immobility and
dystonia.
There were no signs of spasticity. Muscle wasting of the lower
limbs was observed, but given the results of neurophysiological
measurements this might be more likely to result from immobility
rather than from primarymyopathy ormotor neuropathy. All affected
individuals had sensory complaints; two had non-specific pain in
their joints and the remaining three experienced paraesthesia or
‘burning sensation’ in their limb peripheries, joints and trunk. Pain
sensationwas tested in individuals II:5 and II:6 and found to be absent
in the upper limbs and face but preserved in the trunk and lower limbs.
Seizures were experienced only by individual II:1 from the age of
15 years.
All five affected individuals displayed ichthyosis-like whitish
scaling of the skin with more prominent abnormalities on the shin
and scarring alopecia. All five individuals also failed to thrive and
had low weights. They did not display dysmorphic features and their
daily life behavior did not suggest severe cognitive dysfunction or
visual abnormalities. The salient clinical features of the affected
individuals are summarized in Table 1.
Clinical examinations of affected individuals
Otological examination, tympanometry and pure-tone audiometry
were performed in individuals II:1, II:5 and II:6 at the ages of 19, 10,
and eight years, respectively. No external or middle ear
abnormalities were noticed and tympanograms were normal for
both ears. Pure-tone audiograms displayed bilateral, symmetric,
severe or profound hearing impairment, which is sensorineural as
bone conduction thresholds were in accordance with air conduction
thresholds (Fig. 1B). Brainstem-evoked response audiometry
(BERA) was performed for II:1 and II:5 and did not reveal any
waveforms up to 90 dB, for both ears.
There were no signs of muscle damage, liver or kidney
dysfunction as serum levels of glutamic oxaloacetic transaminase
(SGOT), creatine phosphokinase (CPK), lactate dehydrogenase
(LDH) and aldolase were found to be within the normal range
(Table 2). Fasting glucose levels were determined to be normal as
well as fasting serum levels of triglycerides (Table 2).
Nerve conduction studies were performed for individual II:1 at
the age of 14 years. For the left tibial nerve, small compound
muscle action potentials (CMAPs) were measured with normal
motor conduction velocity. Normal CMAP and motor conduction
velocities were observed in the left median and ulnar nerves.
Also, sensory action potentials and conduction velocities in the
left median and ulnar nerves were found to be normal. Needle
EMG was normal in deltoid, anterior tibial and gastrocnemius
muscles. Findings were interpreted as resulting from decreased
muscle bulk.
MRI of the abdomen of individuals II:5 and II:6, and of I:1 as a
control did not demonstrate any signs of lipodystrophy. Values of
Table 1. Clinical features of affected individuals with the homozygous c.4G>T (p.Glu2*) mutation in FITM2
II:1 II:3 II:5 II:6 II:8
Age (years) 26 22 13 9 6
Gender Female Female Male Male Male
Onset of hearing
impairment
(months)
6 6 6 6 6
Current speech Single words Single words Single words Single words Single words
Sensory
disturbances
Frequent pain in joints Frequent pain in joints Daily burning sensation
in peripheries
Daily burning sensation
in peripheries
Daily burning sensation in
peripheries
Autonomic features Urinary incontinence from
12 years; daily diarrhea
from 16 years
Normal Normal Normal Normal
Motor function Delayed walking at
3 years; bedridden by
10 years
Delayed walking at
3 years; loss of
ambulation by 10 years
Delayed walking at
3 years; loss of
ambulation by 10 years
Crawled at 2 years;
never walked
independently
Delayed walking at
3.5 years; unable
to run
Dystonic movements Dystonic limb movements
from 2 years
None Dystonic limb movements
from 2 years
Dystonic limb
movements from
2 years
None
Seizures Daily seizures from
15 years
None None None None
Skin features Ichthyosis-like features,
most prominent at the
shin
Ichthyosis-like features,
most prominent at the
shin
Ichthyosis-like features,
most prominent at the
shin
Ichthyosis-like features,
most prominent at the
shin
Ichthyosis-like features,
most prominent at the
shin
Height (m) 1.36 1.38 1.21 1.06 0.91
Mass (kg) 32.0 31.0 22.0 17.0 15.0
BMI* 17.2 16.1 14.8 15.2 18.1
Age at measurement
(years)
23 19 12 8 5
*For comparison, the BMI of two healthy siblings (II:2 and II:7) was 23.5 and 21.0 at the ages of 22 years and 12 years, respectively.
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liver fat content and subcutaneous adipose tissue (SAT) and visceral
adipose tissue (VAT) volumes were in the normal range. MRI of the
brain with particular attention to the basal ganglia was performed for
individuals II:1 and II:5 and showed no abnormalities, neither in the
basal ganglia nor in other regions. A skeletal muscle biopsy (II:1)
did not reveal myopathic or neurogenic changes.
In summary, the syndrome in the family is characterized by a
novel combination of features: progressive hearing impairment,
delayed development and subsequent regression of motor skills,
dystonia and low BMI. In addition, ichthyosis-like skin changes
are associated with this phenotype and there is a suggestion of
small fiber neuropathy (burning sensations, non-length-
dependent distribution of sensory abnormalities, normal sensory
conduction studies). We propose to call the syndrome ‘Siddiqi
syndrome’ after Dr Saima Siddiqi, who initiated the research in
this family.
Whole-exome sequencing identified a nonsense mutation in
FITM2
Homozygosity mapping and linkage analysis of all family
members revealed a single homozygous region of 8.4 Mb on
chromosome 20q12–q13.2 (rs2903624–rs6096425) (Table S2).
LOD score calculations using 58,023 independent SNPs genome-
wide in linkage equilibrium (pairwise r2 for each SNP <0.1)
revealed a maximum LOD score of 4.00 (Fig. S1). Prolonged
ancestral consanguinity that might reduce the significance of
linkage peaks is highly unlikely as shown by the percentage of
the genomes present in homozygous runs of SNPs (>1 Mb) and
the pairwise checks for familial relationships (Table S3, see also
Fig. S2).
The only linkage region contained 125 genes [USCS Genome
Browser (https://genome.ucsc.edu/), reference sequence hg19].
Whole-exome sequencing (WES) was performed in the non-
affected parents (I:1, I:2) and in two affected siblings, (II:5, II:6).
The single homozygous 8.4 Mb region on chromosome 20q12–
q13.2 was fully covered in the enrichment kit. In the linkage region,
only non-synonymous exonic and canonical splice-site variants
were selected that occurred with a frequency of less than 5% in
the 1000 genomes (http://www.1000genomes.org/) and HapMap
(hapmap.ncbi.nlm.nih.gov) populations, and that were homozygous
in both affected siblings and heterozygous in the parents (Tables S4,
S5). This revealed a single homozygous nonsense mutation in the
second codon, c.4G>T (p.Glu2*, NM_001080472.1; Fig. 2), of
FITM2 that cosegregated in the family with the disease (Fig. 1A;
Table S5). This FITM2 c.4G>T variant was neither present in 274
Pakistani control alleles nor in whole-genome or -exome databases
(see Materials and Methods). In order to exclude other potentially
causative variants, especially in genomic regions with a LOD score
≥−2, we selected all variants with a MAF (minor allele frequency)
<5% that were heterozygous in the parents and compound
heterozygous or homozygous in both affected siblings. These
analyses did not unveil any variants potentially associated with the
syndrome (Tables S5, S6, Fig. S3).
Since postnatal whole-body Fit2 knockout in mouse is lethal
(Goh et al., 2015), we considered the possibility that the present
mutation might not lead to complete loss of FITM2 function,
potentially as a result of downstream alternative translation initiation
sites. We expressed C-terminally Strep/FLAG-tagged wild-type
and p.Glu2* FITM2 in HEK293T cells to identify potential
N-terminally truncated FITM2 proteins. Even after FLAG affinity
purification, no indications for significant amounts of alternative
FITM2 products were obtained (Fig. 2B). We conclude that with
high likelihood the FITM2 mutation results in a complete loss of
FITM2 function.
To further address the involvement of FITM2 mutations in
hearing impairment syndromes with characteristics overlapping
those in the present family, FITM2 was sequenced in six index
individuals with deafness and a sensory polyneuropathy. Also, four
index cases were tested who were suspected to be presenting with
Mohr–Tranebjaerg syndrome and who did not carry TIMM8A
mutations. Mutation analysis did not reveal biallelic variants of
FITM2 with allele frequencies <5% in the HapMap, 1000 genomes
or Exome Aggregation Consortium database (ExAC; http://exac.
broadinstitute.org/) databases.
Drosophilamodels of FITM2
To gain independent support for the role of FITM2 in the phenotype
of the presented family and to dissect the underlying tissue-specific
pathologies, we studied FITM function in Drosophila
melanogaster. The Drosophila genome harbors a single, thus far
uncharacterized, gene representing the human FITM protein family
(FITM1 and FITM2), CG10671, which we accordingly name Fitm.
FITM1 and FITM2 share 25% amino sequence identity with their
annotated ortholog Fitm (see http://www.ensembl.org/). According
to ModEncode and FlyAtlas expression databases (Chintapalli
et al., 2007; Graveley et al., 2011), Fitm is expressed widely
throughout developmental stages and tissues, with highest
expression in adult fat body, heart and carcass. The lack of
genetic redundancy of Fitm inDrosophila suggests that its complete
absence in a null mutant is likely to lead to lethality in early stages
of development. Therefore, we decreased the expression of Fitm
by constitutive RNA-mediated interference (RNAi) with the
UAS-GAL4 system. The efficacy of Fitm downregulation was
determined by qRT-PCR upon ubiquitous knockdown using the
αTub84B-GAL4 driver. All RNAi lines presented comparable
levels of Fitm downregulation with respect to the corresponding
control line. The decrease in Fitm transcripts was 92% (P=0.003)
for Fitm RNAi-1A, 80% (P=0.008) for Fitm RNAi-1B and 80%
for Fitm RNAi-2 (P=0.008) as compared with the respective
control lines (Fig. S4). Since RNAi-1A and -1B carry the same
RNAi construct, we prioritized RNAi-1A and RNAi-2 lines for our
experiments. For the experiments that did not give conclusive data
for one of the tested conditions and allowed the use of females, we
additionally investigated the X chromosome-linked RNAi line
RNAi-1B.
Table 2. Biochemical evaluation of serum and liver fat content of
affected subjects
Measurements II:1 II:5 II:6 Control values
Fasting glucose
(mg/dl)
101 110 94 60-110
SGOT (AST) (U/l) 27 (32) 25 (38) ND In brackets per
individual
CPK (U/l) 136 (26-140) 150 (38-174) ND In brackets per
individual
LDH (U/l) 263 397 ND 240-480
Aldolase (U/l) 4.5 (0.1-7.6) 3.0 (0.2-15.2) ND In brackets per
individual
Urea (mg/dl) 30 45 ND 10-50
Creatinine (mg/dl) 0.8 0.7 ND 0.7-1.19
Triglycerides
(mmol/l)
ND 1.31 1.21 <1.7
Liver fat (%) ND 3.63 ND <10%
SGOT, serum levels of glutamic oxaloacetic transaminase; CPK, creatine
phosphokinase; LDH, lactate dehydrogenase; ND, not determined.
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Knockdown of Drosophila Fitm causes locomotor impairment
To address locomotor function, impaired in the presented family, we
first subjected Fitm knockdown models to an explorative negative
geotaxis test in which climbing capacity was visually evaluated.
Flies with Fitm knockdown mediated by the αTub84B-GAL4 and
Mef2-GAL4 drivers displayed a decreased climbing capability at 4,
12 and 21 days after eclosion (Movie 1). The latter driver is highly
expressed in muscle cells. Upon Fitm knockdown mediated by the
fat-body-specific C7-GAL4 driver, flies were severely impaired in
climbing at day 21, although normal at days 4 and 12 after eclosion.
This locomotion phenotype was highly consistent in both RNAi
lines tested with ubiquitous, preferential skeletal muscle and fat
body promoters. Pan-neuronal knockdown of Fitmwith thew;UAS-
Dcr-2; elav-GAL4 driver and w, UAS-Dcr-2; n-syb-GAL4 did not
lead to obvious anomalies, flies showed normal climbing behavior.
To further characterize the locomotor abilities of Fitm
knockdown flies in a quantitative manner, the island assay
(Schmidt et al., 2012) was performed using the two driver lines
that resulted in impaired climbing in the negative geotaxis test. This
revealed that ubiquitous Fitm knockdown leads to severe locomotor
impairment, resulting in significantly higher numbers of flightless
flies at days 4 and 12 after eclosion (P<0.0001; Fig. 3A). Upon
downregulation of Fitm using the Mef2-GAL4 driver, more than
98% of the flies displayed a flightless phenotype at 4 and 12 days
old (P<0.0001 for all analyzed conditions; Fig. 3B). The effect of
fat-body-specific Fitm knockdown on locomotion was evaluated
because of the evolutionary conserved role of FITM2 in LD
biogenesis in adipose tissue (Kadereit et al., 2008; Miranda et al.,
2014) and because of high Fitm expression in Drosophila fat
bodies. In agreement with this, a progressive locomotor
impairment was observed. A maximum of 13% flightless flies
were observed at 4 days past eclosion and a minimum of 51%
flightless flies were observed at 12 days, which further raised to
more than 78% at 21 days past eclosion (P<0.001 for all analyzed
conditions; Fig. 3C). Pan-neuronal knockdown of Fitm with
the w; Dcr-2; elav-GAL4 and w, UAS-Dcr-2; n-syb-GAL4 drivers
did not lead to any significant locomotor impairment in the island
assay (Fig. S5).
We visually evaluated body and wing movements of the
flightless flies, as sensory motor coordination is essential for flight
initiation and a sensory neuropathy is part of the phenotype in the
Pakistani family. At the initiation of flight, flies first raise their
wings to a stable position that will be held for a few seconds before
take-off (Card and Dickinson, 2008). In a subset of Fitm
knockdown flies, but not in controls, these flight initiation
movements were uncoordinated. The knockdown flies failed to
upstroke their wings for takeoff and instead displayed fast wing
movements, and uncontrolled jumping and shaking of their corpus
(Movie 2). Upon pan-neuronal Fitm knockdown, flies did not
display this phenotype.
Fig. 2. Identification of a genetic defect underlying syndromic hearing impairment in familyW09-1008 and expression analysis of wild-type and p.Glu2*
FITM2 fused to a FLAG-tag in HEK293T cells. (A) Partial sequences of FITM2 exon 1 are shown from an affected member, an unaffected heterozygous sib and
an unaffected wild-type sib of family W09-1008. The predicted amino acid changes and the surrounding amino acids are indicated above the sequence.
Sequence NM_001080472.1 was employed as a reference. (B) The left panel shows a western blot of a gel on which 10% of the cell lysate was loaded (before
affinity purification). The right panel shows a western blot of a gel on which 10 µl of the lysate after affinity purification (anti-FLAG) was loaded. Wild-type (WT)
FITM2 migrates around 29 kDa and it is absent upon transfection and expression of the p.Glu2* FITM2 construct. After affinity purification, a very weak band is
observed at∼16 kDa. However, the intensity of the 16 kDa band is about 2700-fold lower than thewild-type FITM2 band and therefore it is likely to have little or no
biological impact. The gel was immunostained with an anti-FLAG polyclonal antibody. Of four ATG-triplets in the original reading frame, three (codon positions 94,
493 and 508) are predicted to be potential translation initiation sites by the Netstart 1.0 algorithm (Pedersen et al., 1997). Accordingly, alternative proteins would
consist of 285 amino acids (aa) (26.2 kDa), 152 aa (11.2 kDa), and 147 aa (10.6 kDa), respectively. Expression constructs encode FITM2 fused to a C-terminal
Strep-FLAG-tag (SF-TAP), adding approximately 6 kDa to the proteins. Wild-type FITM2 was found tomigrate according to molecular weight of∼29 kDa, which is
lower than the predicted mass of the complete protein. However, fragments of similar length are observed with anti-FITM2 staining in the work of Duckert et al.
(2004) and pro-peptide cleavage is predicted by the ProP algorithm. Marker size is indicated between the panels and given in kDa.
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In conclusion, loss of Fitm expression in Drosophila causes
locomotor defects and Fitm knockdown preferentially in muscle or
specifically in the fat body suffices to induce this phenotype.
Downregulation of Fitm causes abnormal dendrite branching and
field coverage of Drosophila multi-dendritic sensory neurons
As signs of a sensory neuropathy are part of the syndrome caused by
a nonsense mutation in FITM2, we evaluated the role of Fitm in
sensory neuron development by inspecting the dorsal class IV
dendritic arborization C (ddaC) neurons in third instar larvae. These
nociceptive neurons show a complex, but rather stereotypic
dendritic branching with a large field of coverage (Fig. 4A) that,
together with other class IV dendritic arborization neurons, tile the
larval body wall. Fitm expression was downregulated by RNAi in
class IV dendritic arborization neurons using a combination of the
477-GAL4 and ppk-GAL4 drivers, which simultaneously induce
expression of the fluorescent marker UAS-mCD8::GFP. A driver
line with a combination of two GAL4 elements was used to increase
the number of GAL4 molecules to bind UAS-mCD8::GFP, UAS-
Fitm RNAi and UAS-Dcr-2 to enhance their expression.
Knockdown of Fitm upon induction of Fitm RNAi-1A resulted in
a strong reduction of the dendritic field coverage in a subset of
larvae (5 of 18 analyzed), with contact with the neighboring
sensory neurons being completely absent (Fig. 4B). Fig. S6 shows
the obtained microscopic images of the traced neurons and
representative images of untraced neurons of knockdown flies that
were evaluated as normal. A dendritic field coverage defect
phenotype was also observed in a Fitm RNAi-2 larva, but only
occurred in one of 40 larvae analyzed (Fig. S7A-F). It was, however,
never observed in any control larva, either during this or other
studies (Mukhopadhyay et al., 2010; Kramer et al., 2011; Klein
et al., 2015). Reduced penetrance of RNAi-induced phenotypes is a
known phenomenon and could be dependent on the timing and
efficiency of knockdown (Mauss et al., 2009; Godenschwege et al.,
2006). In our experiment, we used genetic tools and conditions to
maximize RNAi efficiency (two driver elements, UAS-Dcr-2, and a
temperature of 28°C). Alternatively, reduced penetrance can also be
observed in null mutants when the function of the affected gene can
partially be compensated by others (Raj et al., 2010; Chalancon
et al., 2012; Cooper et al., 2013).
To gain more insight in the underlying defects of the abnormal
field coverage, we performed manual tracing and quantitative
analysis on the control and abnormal Fitm RNAi-1A dendritic trees
(Fig. 4C-G; Tables S8, S9). Sholl analysis showed that the dendritic
field coverage of controls has a maximum radius of 350±21 μm
(mean±s.e.m.), the dendritic field coverage in Fitm RNAi-1A is 60%
the size with a significantly smaller radius of 210±39 μm (P=0.0001;
Fig. 4C). Analysis of the dendritic trees revealed a reduced average
branch path length (P=0.01; Fig. 4D), defined as the distance between
two branching points, a reduced accumulative branch path length
(P≤0.0001; Fig. 4E), defined as sum of the distance of all branches
contained in a neuron, and a decreased number of branches
(P≤0.0001; Fig. 4F); all in concordance with the reduced field of
coverage. The maximal branch order was not significantly decreased
(P=0.2; Fig. 4G), defined as the order of a branch with respect to the
soma; each branching point will lead to brancheswith a higher branch
order. Although only one Fitm RNAi-2 larva was found to be
affected, some aspects are similar to the RNAi-1A phenotype.
Analysis of the affected Fitm RNAi-2 dendritic tree revealed low
average branch path length and accumulative branch path length
(Fig. S7C,D, respectively), but the number of branches and branch
order were high (Fig. S7E,F; Table S10).
Fig. 3. Knockdown of Fitm impairs locomotor abilities in Drosophila.
Stacked bar graphs show the average percentage of flightless flies (black
bars) and flies with normal flight responses (white bars). Error bars
represent s.e.m. The indicated days represent days of age past eclosion.
Fitm knocked down ubiquitously and preferentially in skeletal muscle with
the αTub84B-GAL4 (A) and Mef2-GAL4 (B) promoters, respectively, and
Fitm RNAi-1A and Fitm RNAi-2 showed significant locomotor impairment
at all time points. (C) Fitm knockdown in the fat body (C7-GAL4 driver)
using Fitm RNAi-1A and Fitm RNAi-2 revealed a progressive locomotor
impairment evident at 12 days after eclosion as compared with
corresponding age-matched control flies. The percentages of normal and
flightless flies per experiment was used to determine statistical
differences by one-way ANOVA with Tukey’s correction for multiple
testing, *P<0.05, **P<0.01. Average percentages are plotted in the
graphs. The n refers to the number of experiments. Number and
percentages of flightless and normal flies in each independent
experiment can be found in Table S7.
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Taken together, our results suggest that Fitm is required for
normal branching and dendritic field coverage in a subset of
Drosophila ddaC nociceptive sensory neurons.
Fitm is required for normal hearing in Drosophila
Affected members of the presented family displayed postnatal
sensorineural hearing impairment that progressed to profound.
Therefore, we tested whether Fitm is implicated in Drosophila
hearing by analyzing sound-evoked mechanical and electrical
responses of the antennal hearing organ (Fig. 5) upon ubiquitous or
pan-neuronal knockdown. To evoke sound responses, we exposed
the flies to pure tones of different intensities at the individual
mechanical best frequency of their antennal sound receiver (Göpfert
et al., 2006). The resulting vibrations of this receiver were measured
as well as the ensuing compound action potentials (CAPs)
propagated by the axonal projections of the fly’s auditory sensory
neurons in the antennal nerve (Fig. 5A). In genetic background
controls, sound particle velocities exceeding ∼0.05 mm s−1 evoked
CAP responses (Fig. 5B), consistent with published data on wild-
type flies (Senthilan et al., 2012). As in wild-type flies, the sound-
induced displacement of the antenna also scaled nonlinearly with
the intensity of sound stimulation (Fig. 5A), displaying a
compressive nonlinearity that, arising from motile responses of
auditory sensory neurons, actively amplified the antennal
displacement response to faint sounds with an amplification gain
of approximately seven (Fig. 5C). Ubiquitous knockdown of Fitm
with Fitm RNAi-1A significantly increased the threshold of the
sound-evoked CAP responses (Fig. 5B; Table S12), documenting a
loss in auditory sensitivity. Auditory sensitivity seemed
uncompromised by pan-neural knockdown with Fitm RNAi-1A
and knockdown with Fitm RNAi-1B or RNAi-2 (Fig. 5C), yet
significant hearing impairment was detected in all three RNAi lines
upon ubiquitous knockdown when we examined the nonlinear
scaling of their antennal vibrations. RNAi-1A- and RNAi-1B-
induced knockdown reduced this nonlinear scaling, significantly
lowering the mechanical amplification gain (Fig. 5C; Table S12).
Moreover, all three knockout constructs significantly increased the
best frequency of the antennal sound receiver (Fig. 5D; Table S12),
documenting defects in the active frequency tuning of the receiver,
which is achieved through mechanical amplification.
Together, these results document that Drosophila auditory
sensory neurons require Fitm for normal mechanical amplification
in hearing, which is linked to auditory stimulus transduction and
auditory neuron integrity (Senthilan et al., 2012).
Fitm is important for lipid droplet size in the fat body of adult
Drosophila
Having shown a number of parallels between human and
Drosophila phenotypes, we finally sought to evaluate whether
Drosophila Fitm functions in LD formation, as previously reported
in other organisms (Kadereit et al., 2008; Gross et al., 2011;
Choudhary et al., 2015; Miranda et al., 2014). We thus knocked
down Fitm expression in the fat body and evaluated LD size. Fitm
RNAi-1A and RNAi-1B knockdown flies demonstrated a
diminished LD size as compared with flies of the background line
at 4, 12 and 21 days after eclosion (Fig. 6). The Fitm RNAi-2
knockdown flies exhibited a reduction in LD size that started at
12 days after eclosion (Fig. 6A). Strikingly, all RNAi lines showed a
progressive phenotype; the reduction in the LD size was milder or
nonexistent in young flies (4 days after eclosion) and more severe in
ageing flies (12 and 21 days after eclosion) (Fig. 6A,B).
Fig. 4. Fitm RNAi-1 knockdown in Drosophila interferes with
morphology of nociceptive multi-dendritic sensory neurons.
(A,B) Confocal projections of class IV da neurons within segment A3 of third
instar larvae, visualized with the class IV da-specific drivers 477-GAL4 and
ppk-GAL4 and UAS-mCD8::GFP. The ddaC neurons show abnormal
dendritic morphology in a subset of Fitm RNAi larvae. (A) Control-1 shows
ddaC contact to neighboring neurons. (B) Knockdown of Fitm in line RNAi-1A
results in a severe outgrowth defect, observed in 5/18 larvae. The five highly
abnormal neurons (see Fig. S6) were analyzed further, to test whether they
significantly differ from the control. (C) Sholl analysis (Wearne et al., 2005) of
control (n=5) and selected highly abnormal neurons (n=5) reveals defects as
a measure of the soma distance. The Fitm RNAi-1A dendritic field coverage
has a radius that is 60% the size of that of the control. (D-G) Quantitative
analysis of dendritic trees reveals that the affected Fitm RNAi-1 neurons have
(D) a reduced average branch path length (P=0.01), (E) a reduced
accumulative branch path length (P≤0.0001), (F) a decreased number of
branches (P≤0.0001), and (G) not significantly changed maximal branch
order (P=0.2). Dorsal is up in A,B. Scale bar: 100 μm. Error bars in (D-G)
indicate s.e.m. t-test between control and knockdown conditions was
performed for each parameter to determine significance. P-values are
depicted in each graph. Five neurons per strain, derived from five different
larvae, were analyzed. The data were collected in two independent
experiments. For underlying numerical data see Tables S8 and S9. More
information about the depicted parameters can be found in Table S11.
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We conclude that Fitm function in LD formation is conserved in
Drosophila (Kadereit et al., 2008).
DISCUSSION
We have described a family with a novel homozygous truncating
mutation, c.4G>T (p.Glu2*), in FITM2. Affected individuals
display Siddiqi syndrome, a novel syndrome characterized by
progressive sensorineural hearing impairment, delayed motor
development and subsequent regression, low BMI, ichthyosis-
like skin alterations and signs of a small fiber neuropathy.
Dystonia was observed in some of the affected individuals and
seizures and chronic diarrhea only in the oldest affected sibling.
The chronic diarrhea might well be a symptom of malabsorptive
enteropathy which is seen in mouse upon postnatal Fit2 deletion
(Goh et al., 2015). The combination of the disease characteristics
is novel, although observed phenotypic characteristics in the
Fig. 5. Knockdown of Fitm impairs Drosophila hearing. Antennal vibrations and ensuing antennal nerve potentials were measured in the Fitm RNAi-1A, Fitm
RNAi-1B and FitmRNAi-2 lines and the corresponding controls (Control-1 and Control-2) crossed to the pan-neuronal elav-GAL4 and ubiquitous αTub84B-GAL4
drivers three days after eclosion. (A) Sound-evoked antennal displacement amplitudes (upper panels, log scale) and normalized compound action potential
(CAP) amplitudes as functions of the sound particle velocity. Each circle indicates a single data point. Solid (upper panels) and dashed (lower panels) lines
indicate linear auditory mechanics, as observed upon the loss of mechanical amplification by auditory sensory neuronmotility (Senthilan et al., 2012), and Hill fits
to the pooled CAP responses of each strain, respectively. Red arrows indicate significant differences to controls. (B) Respective CAP thresholds, deduced from
Hill fits to the CAP amplitudes of each individual. (C) Respective mechanical amplification gains provided by auditory sensory neuron motility. (D) Respective
mechanical best frequencies of the antennal sound receivers, deduced from the mechanical fluctuations in the absence of sound stimulation (Senthilan et al.,
2012). Per strain, five flies were analyzed and three independent measures were taken. Each data point represents the average response to 10 stimulus
presentations. Error bars indicate s.d. *P<0.05; ns, not significant by two-tailed Mann–Whitney U-tests. If applicable, Bonferroni correction was used to correct for
multiple testing. For original values, see Table S12.
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family overlap with several known monogenic neurological
conditions such as Troyer syndrome (MIM #275900) and
deafness-dystonia syndromes including Mohr–Tranebjaerg
syndrome (MIM #304700) and Megdel syndrome (MIM
#614739). To delineate Siddiqi syndrome, further families with
FITM2 mutations need to be identified and evaluated clinically.
Currently, it cannot be excluded that part of the phenotype results
from mutations in other genes, especially the characteristics seen
in only some of the cases. However, no homozygous rare variants
were identified in individuals II:5 and II:6 in autozygous regions
(>1 Mb) shared by II:1, II:5 and II:6 only. Also, these regions do
not harbor genes known to be associated with dystonia. Similarly,
regions uniquely autozygous in II:1 do not harbor potentially
pathogenic heterozygous variants in both parents to explain
seizures and diarrhea. Defects in known deafness genes that could
explain the hearing loss only were also not identified. The
causative association of the syndrome with a loss-of-function
mutation in FITM2 is supported by modeling of the disease in
Drosophila melanogaster, which has been proven to be a suitable
model for studying conserved aspects of lipid metabolism and LD
biology (Tian et al., 2011; Baker and Thummel, 2007). RNAi
knockdown of the single Drosophila Fitm ortholog recapitulated
hearing impairment, locomotor defects and abnormalities of the
sensory system.
Sensorineural hearing impairment is the first symptom of Siddiqi
syndrome. The audiometric evaluations did not allow us to
discriminate whether the hearing impairment has a cochlear or
retrocochlear neuronal origin. The hearing phenotype resulting
from Fitm knockdown in Drosophila reflected impaired auditory
stimulus transduction and auditory sensory neuron function, which
support a sensorineuronal hearing impairment in the human
phenotype. A cochlear component might well contribute to
progressive dysfunction of the auditory system in the affected
individuals. LDs are prominent constituents of Hensen cells, which
are highly specialized cells in the organ of Corti, and these Hensen
cell LDs have been suggested to play a role in anti-inflammatory
Fig. 6. Fitm knockdown leads to progressive decrease of lipid droplet size. (A) Representative images of lipid droplets (LDs) labeled with Bodipy (red) in fat
bodies of C7-GAL4-induced Fitm knockdown flies (Fitm RNAi-1A and Fitm RNAi-1B) as compared with the corresponding genetic background control flies at the
indicated time points past eclosion. Nuclei were stained with DAPI (blue). Scale bar: 10 µm. (B) LD area is significantly reduced at 4, 12 and 21 days after eclosion
upon Fitm knockdown with RNAi-1A and RNAi-1B constructs, and with RNAi-2 at 12 and 21 days after eclosion. The graphs display the mean LD area per
experimental condition. Error bars represent the 95% confidence interval. **P<0.01 by ANOVA with Tukey correction. The number of images analyzed, the
number of female flies per strain selected for this analysis and the mean size of lipid droplet per condition are, respectively, as follows. At 4 days: RNAi-1A (11, 5,
10.49 μm); RNAi-1B (14, 6, 6.33 μm); Control-1 (10, 4, 14.73 μm); RNAi-2 (17, 4, 11.86 μm); Control-2 (22, 6, 10.66 μm). At 12 days: RNAi-1A (38, 5, 9.31 μm);
RNAi-1B (33, 6, 5.14 μm); Control-1 (24, 6, 22.52 μm); RNAi-2 (29, 5 15.16 μm); Control-2 (18, 6, 21.95 μm). At 21 days: RNAi-1A (16, 5, 5.14 μm); RNAi-1B (21,
7, 11.49 μm); Control-1 (31, 4, 18.56 μm); RNAi-2B (18, 6, 7.63 μm); Control-2 (32, 6, 11.44 μm). Quantification of lipid droplet size was performed in one
experiment. The observation of progressively reduced lipid droplet sizes in the RNAi-lines was made in three independent experiments.
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responses to prevent cochlear damage (Merchan et al., 1980; Bell
and Fletcher, 2004; Kalinec et al., 2009; Urrutia and Kalinec, 2015).
Additionally, a mechanical function in modulating sound detection
has been proposed for LDs in Hensen cells (Merchan et al., 1980).
However, whether vestibular dysfunction is part of the inner ear
phenotype could not be evaluated, and it therefore remains
undetermined whether impaired balance contributed to the
delayed motor development of the subjects.
Of note is that affected individuals do not have signs of a
lipodystrophy, which is in contrast to findings in mice where post-
differentiation adipose-specific knockout of Fit2 results in
progressive reduction of white adipose tissue (Miranda et al.,
2014). Functional redundancy in human adipose tissue might exist
for FITM2 through FITM1, which is apparently not the case in the
mouse. In the mouse, FIT2 is prominently expressed in adipose
tissue in which FIT1 was not detected (Kadereit et al., 2008). The
relative expression levels of FITM1 and FITM2 in human adipose
tissue is hitherto unknown. A further explanation for the
discrepancy in lethality of FITM2/Fit2 loss of function could be
the presence of alternative sites of transcription start in humans,
resulting in mRNAs that are not affected by the FITM2 variant.
Our experimental setup for detection of alternative translation
initiation sites cannot exclude such alternative transcription start
sites.
The molecular mechanism(s) underlying Siddiqi syndrome are
still elusive but might well be related to one of newly discovered
functions of LDs (Welte, 2015; Barbosa et al., 2015). Disturbance
of energy metabolism and homeostasis might be part of the
underlying mechanism(s), as has been suggested for some other
deafness-dystonia syndromes (Jin et al., 1996; Elpeleg et al., 2005;
Engl et al., 2012). In this respect, it is interesting that
overexpression of Fit2 in mouse skeletal muscle reportedly leads
to increased energy expenditure, indicating an unexpected function
of FIT2 in regulatory aspects of energy metabolism (Miranda
et al., 2011), which might be crucial in tissues that are affected in
the described individuals. In connection to this, it is tempting to
speculate that altered (regulation of ) mitochondrial function is part
of the molecular mechanisms of the disease as indications are
increasing for a functional connection between LDs, and thus
FITM2, and other organelles including mitochondria (Barbosa
et al., 2015). Interestingly, mitochondrial dysfunction is indicated
to underlie some other deafness-dystonia syndromes e.g. Mohr–
Tranebjaerg syndrome with defects in TIMM8A. TIMM8A is
located in the mitochondrial intermembrane space and functions in
mitochondrial morphology (Engl et al., 2012). Alternative and/or
additional pathogenic mechanisms for the presented syndrome
might be related to ER-stress, analogous to the disease mechanism
of motor neuropathies that arise from gain-of-function mutations
in BSCL2, which encodes seipin, a protein that functions in LD
biogenesis (Ito and Suzuki, 2009; Cartwright et al., 2015).
Additionally, recently proposed roles of LDs in, e.g. immunity,
modulation of nuclear functions, protein degradation, autophagy
and lipid signaling might contribute to the pathogenesis of the
syndrome (Welte, 2015; Pol et al., 2014). Further studies will be
needed to elucidate the molecular mechanisms underlying the
syndrome.
In conclusion, we have described a novel deafness-dystonia
syndrome that is causally related to a loss-of-function mutation in
FITM2, the phenotypic effects of which are recapitulated in a
Drosophila model. The phenotype of the affected individuals
suggests that in humans, FITM2 function extends beyond its roles in
neutral lipid storage and metabolism.
MATERIALS AND METHODS
Patient evaluation
Written informed consent was obtained from individuals I:1 and I:2 and
included consent for themselves and for their offspring whowere not able to
sign and/or were younger than 18 years when the genetic studies were
performed. The human subjects review boards of the Institute of Biomedical
and Genetic Engineering, Islamabad, Pakistan, the medical ethics
committee of the Radboud University Medical Center, Nijmegen, the
Netherlands (2010-418), and the Domain Specific Review Board for ethics
of the National Healthcare Group, Singapore (2012/00295) approved the
study protocol. All clinical investigations were performed according to the
principles expressed in the Declaration of Helsinki.
Patients of the presented family (W09-1008; Fig. 1A) were evaluated by
medical specialists in pediatrics, otorhinolaryngology, and neurology.
Tympanometry, pure-tone audiometry, brainstem-evoked response
audiometry (BERA), magnetic resonance imaging (MRI) of the brain,
measurements of fasting levels of glucose and triglycerides and of other
molecules in serum and neurophysiological evaluations were performed
according to standard protocols. Muscle tissue derived from a musculus
vastus lateralis biopsy was embedded in paraffin and stained with
hematoxylin-eosin according to standard protocols.
MRI of abdomen
The abdominal MR images were acquired from a 3T MR scanner (Tim Trio
Siemens) using two-point Dixon sequence repetition time (TR)=5.28 ms,
echo time (TE)1=2.45 ms, TE2=3.68 ms, FA=9°, bandwidth1=
500 Hz Px−1, bandwidth2=780 Hz Px−1 and Siemens body matrix coil
after anatomical localization. For the parent (I:1), 80 axial slices with 3 mm
thickness, 0.6 mm interslice gap and in-plane resolution of 1.25×1.25 mm
were acquired and 52 slices with in-plane resolution of 1.02×1.02 mm were
acquired for two affected children (II:5 and II:6). A fully automated
segmentation technique was employed to segment and quantify the
abdominal fat volumes between the first (L1) and fifth (L5) lumbar
vertebrae (Sadananthan et al., 2015). First, the fat tissues were separated
from non-fat tissues by intensity thresholding. The extracted fat tissues were
then classified into subcutaneous (SAT) and visceral (VAT) adipose tissues
using graph theoretic segmentation.
MR spectroscopy of the liver
Fat content in the liver was determined using 1H magnetic resonance
spectroscopy (MRS). The liver spectra were obtained from a 2×2×2 cm3
voxel from two locations (right and left lobes) using a point-resolved
spectroscopy (PRESS) sequence (TE=30 ms, TR=2000 ms) and a Siemens
body matrix coil. The acquired spectra were fitted using the linear
combination of model spectra (LCModel) (Sadananthan et al., 2015;
Provencher, 1993). The liver fat was determined from the concentration of
methyl and methylene groups of lipids and the unsuppressed water signal
and corrected for T2 losses (Cowin et al., 2008).
Genetic analyses
SNP genotyping
Genomic DNAwas isolated from peripheral blood lymphocytes by standard
procedures. All family members were genotyped employing the
HumanOmniExpress BeadChip v1.1 (Illumina) arrays with 719,659 SNPs.
Homozygosity mapping using 696,513 autosomal SNPs with genotype calls
in all samples (364,151 polymorphic) using PLINK v1.07 was performed
(Purcell et al., 2007). Overlapping homozygous regions >5Mb in size present
in all affected and absent in the unaffected individuals were selected. Family
relationships among genotyped individuals using identity-by-descent checks
were performed. We further conducted a genome-wide linkage scan using
MERLIN 1.1.2 on a pruned subset of 53,028 independent SNPs (defined as
pair-wise r2<0.1), as the inclusion of SNPs in strong linkage disequilibrium is
known to result in inflation of linkage tests, based on inheritance of the same
ancestralmutant allele (0.001) fromboth parents (coded as first cousins) under
a recessive model (Abecasis et al., 2002).
We confirmed the reported familial relationships among genotyped
samples using PLINK identity by descent (IBD) analysis (–genome), with
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parent-offspring pairs sharing ∼50% of alleles IBD and ∼100% of loci
sharing 1 out of 2 alleles IBD, and full sibling pairs sharing ∼50% alleles
IBD with the expected ∼25% of loci sharing 0 alleles IBD, ∼50% sharing 1
allele IBD and ∼25% sharing 2 alleles IBD.
Sequence analysis; WES and Sanger sequencing
Whole-exome sequencing was performed in the non-affected parents, I:1
and I:2, and in two affected siblings, II:5 and II:6, using the Nimblegen
SeqCap EZ exome v3 kit and protocol (Roche). The captured libraries were
barcoded, pooled and sequenced on a single lane in a multiplexed 2×101 bp
Illumina HiSeq 2000 sequencing run. Reads were mapped against the
UCSC Genome Browser Hg19 assembly (build 37) using BWA v1.7 and
variants were called using the Genome Analysis Toolkit (GATK) v2 (Broad
Institute) following the recommended guidelines. Mean sequence depth was
79.5× with >96% of the exome covered by ≥10 reads. Identified variants
were evaluated with the SIFT tool (http://sift.jcvi.org/) and checked against
public databases of exomic or genomic variants [1000 genomes, HapMap
and NHLBI exome variant server (http://evs.gs.washington.edu/EVS/)].
Primers for amplification of exons and exon-intron boundaries of FITM2
(uc002xlr.1) were designed with ExonPrimer (Helmholz Center Munich,
Institute of Human Genetics; https://ihg.helmholtz-muenchen.de/ihg/
ExonPrimer.html). Amplification by PCR was performed on 40 ng of
genomic DNA with Taq DNA polymerase (Roche) or Amplitaq (Life
Technologies). Primer sequences are provided in Table S1. PCR fragments
were purified with NucleoFast 96 PCR plates (Clontech) in accordance with
the manufacturer’s protocol. Sequence analysis was performed with the ABI
PRISM BigDye Terminator Cycle Sequencing V2.0 Ready Reaction kit and
analyzed with the ABI PRISM 3730 DNA analyzer (Applied Biosystems).
Presence of the FITM2 c.4G>T transversion was determined in 137
ethnically matched healthy controls by restriction analysis of amplicons
encompassing FITM2 exon 1 (primers as indicated in Table S1), which were
purified as described above and digested with NspI (New England Biolabs)
in accordance with the manufacturer’s protocol. Restriction fragments were
analyzed on 2% agarose gels. The mutation removes a restriction site. The
absence of the FITM2 c.4G>T variant was also verified in the Nijmegen
WES database (5031 exomes) and ExAC (65,000 exomes). The variant was
submitted to the Leiden open variation database (LOVD; ID #0000079006;
http://databases.lovd.nl/).
Expression analysis of FITM2 in HEK293T cells
Wild-type and c.4G>T FITM2 cDNA were cloned in an expression vector
containing a C-terminal Streptavidin-FLAG-tag (SF-TAP) (Gloeckner et al.,
2007) using Gateway Cloning technology (Life Technologies) according to
the manufacturer’s instructions. Only the protein-coding FITM2 sequences
are represented in the construct (NM_001080472.1). HEK293T cells were
cultured in high-glucose DMEM AQmedia (Sigma Aldrich), supplemented
with 10% FCS, 1% penicillin/streptomycin and 1 mM sodium pyruvate. For
DNA transfections, HEK293T cells were seeded in 6-well plates, grown
overnight, and transfected with 2 µg of plasmid using PEI transfection
reagent (Merck Millipore). Twenty-four hours after transfection cells were
washed with PBS and lysed on ice in lysis buffer [50 mM Tris-HCl pH 7.5,
150 mM NaCl, 0.5% Triton X-100 supplemented with complete protease
inhibitor cocktail (Roche)]. Affinity purification of SF-TAP-tagged proteins
was performed on cleared lysates using anti-FLAG M2 affinity gel (Sigma
Aldrich). Lysates were incubated for four hours at 4°C and subsequently
precipitated by centrifugation and washed three times in lysis buffer. Protein
lysates and affinity purified samples were analyzed on western blots of
NuPAGENovex 12%Bis-Tris Protein Gels (Life Technologies) and imaged
using the Odyssey Infrared Imaging System (LI-COR). Tagged molecules
were detected by anti-FLAG antibodies (1:1000; Sigma Aldrich, F7425)
and IRDye800 goat-anti-rabbit IgG (1:10,000; LI-COR, 926-32211) as
described (Roosing et al., 2014).
RNAi and phenotypic analyses in Drosophila melanogaster
Drosophila melanogaster stocks and maintenance
We modeled loss of human FITM2 by constitutive knockdown in
Drosophila, exploiting two independent, inducible RNAi constructs
against both isoforms encoded by CG10671, CG10671-RA and
CG10671-RB, and the UAS-GAL4 system (Brand and Perrimon, 1993;
Dietzl et al., 2007). Experiments were replicated in multiple stocks, two
from the GD RNAi library (v44433 and v44435 harboring the RNAi
construct GD3580; referred to as Fitm RNAi-1A and Fitm RNAi-1B,
respectively) with the corresponding genetic background control (v60000;
Control-1) and one from the KK RNAi library (v109895 with the RNAi
construct KK107999; Fitm RNAi-2) with the corresponding genetic
background control (v60100; Control-2). The stocks were obtained from
the Vienna Drosophila RNAi Centre (VDRC; http://stockcenter.vdrc.at/
control/main) (Dietzl et al., 2007).
RNAi expression was induced by a variety of GAL4 driver lines, which
carry a tissue-specific promoter driving the expression of GAL4. Thew; C7-
GAL4; UAS-Dcr-2 (fat body expression) linewas kindly provided byMarek
Jindra (Rynes et al., 2012). The GAL4 promoter driver lines, w;; αTub84B-
GAL4/ TM6C, Sb1 Tb1 (5138) (ubiquitous expression) and w, UAS-Dcr-2;
Mef2-GAL4 (25756) (preferentially expressed in skeletal muscle) were
obtained from the Bloomington Drosophila Stock Center (BDSC; http://
flystocks.bio.indiana.edu/). The w;; elav-GAL4 (8760) line was obtained
from the BDSC and combined with w; UAS-Dcr-2 (60009) from VDRC to
create w; UAS-Dcr-2; elav-GAL4 (pan-neuronal expression). A copy of
UAS-Dcr-2 was included to improve the efficiency of knockdown (Dietzl
et al., 2007). Thew, UAS-Dcr-2; 477-GAL4, UAS-mCD8::GFP; ppk-GAL4
driver [expression in class IV dendritic arborization (da) neurons] was
assembled from yw, 477-GAL4; UAS-mCD8::GFP (8768) and w;; ppk-
GAL4 (32079), both from BDSC. Crosses were maintained according to
standard procedures at 28°C.
Confirmation of Fitm knockdown by qRT-PCR
In order to evaluate the efficiency of RNAi-induced knockdown, Fitm
RNAi-1A, Fitm RNAi-1B and Fitm RNAi-2 lines were crossed to the
αTub84B-GAL4 driver (ubiquitous). One-day-old males of the appropriate
genotype were selected for qRT-PCR evaluation of Fitm RNAi-1A and
RNAi-2 lines, one-day-old females for evaluation of knockdown using the
X-linked Fitm RNAi-1B line. Extraction of mRNA, cDNA synthesis and
qPCR were performed as previously described (Mukhopadhyay et al.,
2010). The gene encoding RNA polymerase II (RpII215) was used as a
reference gene. Primer pairs for amplification of both Fitm isoforms
(CG10671-RA and CG10671-RB) and RpII215 transcripts were designed
using ExonPrimer software. For each genotype, three biological and two
technical replicates were performed. Differential gene expression was
calculated using the 2ΔΔCt method (Livak and Schmittgen, 2001). One-way
ANOVA (GraphPad Prism version 5.00 for Windows) was employed for
calculations of P-values.
Negative geotaxis assay
Fitm RNAi lines and the corresponding genetic background control lines
were crossed to the αTub84B-GAL4,Mef2-GAL4 and the C7-GAL4 driver
lines. Female and male progeny of the appropriate genotypes and age were
subjected to the negative geotaxis assay (Benzer, 1967; Ali et al., 2011).
Locomotor climbing abilities where observed after tapping down the flies in
the vials. The natural response of flies is to climb up the vials after tapping.
In case of locomotor impairment, flies exhibit slower climbing behavior or
non-ability to climb.
All behavioral tests were performed at room temperature under standard
light conditions. Aged flies were transferred to fresh food vials every three to
four days.
Island assay
Fitm RNAi lines and the corresponding genetic background control lines
were crossed to the αTub84B-GAL4 (ubiquitous), the Mef2-GAL4
(preferentially expressed in skeletal muscle) and the C7-GAL4 (fat body)
driver lines. Female and male progeny of the appropriate genotypes and age
were subjected to the island assay (Schmidt et al., 2012). In brief, flies were
simultaneously released onto a platform in the middle of a soap bath and
their escape response was videotaped. Flies remaining on the platform after
10 s were manually counted. Flight ability, wing and leg movements were
visually evaluated (Lee et al., 2009). If an abnormal locomotion behavior
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was found, at least one additional experiment was performed to confirm the
observed behavioral defects. The SPSS statistics 20 package (IBM) was
used for the ANOVA statistical comparisons.
All behavioral experiments were performed at room temperature under
standard light conditions. Aged flies were transferred to fresh food vials
every three to four days.
Dendritic morphology of class IV dendritic arborization neurons
Male third instar larvae were dissected following a ventral midline incision
for imaging of the dorsal class IV ddaC neurons. The Fitm RNAi-1A and
Fitm RNAi-2 lines and the corresponding controls were crossed to w, UAS-
Dcr-2; 477-GAL4, UAS-mCD8::GFP; ppk-GAL4 driver line. Dendritic
neurons were stained with rat anti-mouse CD8a (1:100; Thermo Fisher
Scientific, MCD0800) and goat anti-rat Alexa Fluor 488 (1:200; Thermo
Fisher Scientific, A-11006). Z-stack images were taken at a Zeiss LSM 510
confocal microscope with a 20× objective. Z-stacks were imported into
NeuronStudio (version 0.9.92; Wearne et al., 2005; http://research.mssm.
edu/cnic/tools-ns.html) for generation of neuronal reconstructions and Sholl
analysis (10 μm interval). Tracing files were analyzed with L-Measure
(version 5.2; Scorcioni et al., 2008) and statistical significance was analyzed
using the one-sample t-test in GraphPad Prism. Data was collected from
larvae selected from two independent experiments.
Hearing test
To assess sound responses of the Drosophila Johnston’s organ (JO),
antennal vibrations and ensuing antennal nerve potentials were measured in
adult flies three days after eclosion as previously described (Göpfert et al.,
2006). The Fitm RNAi-1A, Fitm RNAi-1B and Fitm RNAi-2 lines and the
corresponding controls were crossed to the elav-GAL4 and αTub84B-GAL4
drivers. In the Fitm RNAi-1B line, the RNAi construct was located in the X
chromosome and therefore only female progeny were evaluated of this
condition and its control. When using the lines Fitm RNAi-1A, Control-1,
Fitm RNAi-2 and Control-2, both females and males were selected. In brief,
antennal vibrations were monitored at the tip of the antennal arista using a
PSV-400 scanning laser Doppler vibrometer (LDV) with an OFV-500
close-up unit (Polytec GmbH). Pure tones adjusted to the mechanical best
frequency of the antenna were used as sound stimuli. The resulting sound
particle velocity was measured with an Emkay NR3158 pressure gradient
microphone (distributed by Knowles Electronics Inc.) at the position of the
fly. In line with previous reports (Göpfert et al., 2006), the individual best
frequency of each antenna was determined from the power spectrum of its
mechanical free fluctuations in the absence of sound stimulation, and tone-
evoked antennal vibration amplitudes were measured as Fourier amplitudes
at the frequency of sound stimulation. Ensuing nerve potentials were
measured in the form of compound action potentials (CAPs) from the axonal
projections of JO neurons in the antennal nerve via an electrolytically
tapered tungsten electrode inserted between the antenna and the head
(Effertz et al., 2011; Senthilan et al., 2012). A tungsten wire inserted into the
thorax served as indifferent electrode. CAP amplitudes were plotted against
the corresponding sound particle velocities. Hill fits were used to determine
the sound particle velocity threshold of the CAPs, whereby the particle
velocity corresponding to 10% of the maximum amplitude approached by
the fit was used as the threshold criterion. To quantify the amplification gain
exerted by motile responses of JO neurons, the antenna’s mechanical
sensitivity, measured as antennal displacement amplitudes normalized to the
corresponding sound particle velocities, was plotted against the particle
velocity of the stimulus tones. The amplification gain was then measured as
the ratio between the antenna’s mechanical sensitivity in the low and high
intensity regimes (Göpfert et al., 2006; Senthilan et al., 2012). Data analysis
was performed using Polytec-VIB (Polytec GmbH), Spike 2 (Cambridge
Electronic Design), Excel 2007 (Microsoft), SigmaPlot 10 (Systat Software)
and Prism (GraphPad).
Fat body analysis
Fitm RNAi lines and the corresponding controls were crossed to the C7-
GAL4 driver line (fat body). Progenywas transferred to vials with fresh food
every two days. Fat bodies of female flies were dissected at the indicated
adult age, fixed in PBS with 3.7% paraformaldehyde for 20 min, rinsed with
PBS, stained with Bodipy (1:2000; Life Technologies, C3922) for 20 min at
room temperature, and mounted in Vectashield with DAPI (Vector
Laboratories). Pictures were obtained using a Zeiss Axio Imager ZI
fluorescence microscope (Zeiss). Data was collected from flies selected
from two independent experiments. LD area was assessed using Fiji (NIH).
A minimum of two random regions of interest (ROI) of 35.5 µm2 were
created from each image and the area of the LDs contained in the ROI was
retrieved and analyzed. Statistical significance was calculated by using
ANOVA with the Tukey correction for multiple testing incorporated in
GraphPad Prism.
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